Data from BAL fluid investigation showed IL-1β, IL-6, Macrophage inflammatory protein-1β (MIP-1β), and TNFα (which was reported as pulmonary fibrosis-related cytokines in BAL [25]) significantly decreased in BP treatment groups (Figure 6A–D. This evidence concerns the gene CCL4 and pulmonary fibrosis.